Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sector of biopharmaceuticals, presenting promising breakthroughs across several medical and industrial applications. With its structural similarity to By natural means derived human serum albumin, OsrHSA delivers a safer, more trusted option for therapeutic use, espec